Clinical trial
A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia
NCT07293728
Study timeline
Study start (estimated)2026-07-01Date precision: month
Registry last updated2025-12-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hypertensionunresolved
Preeclampsiaunresolved
Interventions
Norethindrone 0.35 MGDRUG · verified · RxNorm: norethindrone 0.35 MG
DrospirenoneDRUG · verified · RxNorm: drospirenone
Sponsors & collaborators
Oregon Health and Science Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07293728 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.